Power of softness in mechano-onco-immunology 2025.07.01 Tumor: A Special Metabolic Disease 2025.07.01 Experience in Precision Treatment of Esophageal Cancer 2025.07.01 Progress and Challenges of Novel Immunotherapy Targets 2025.07.01 Following EMA Approval: Toripalimab Establishes New First-Line Standard for Esophageal Cancer 2025.07.01 New Practices in Precision Tumor Immunotherapy 2025.07.01 HER2-targeted Efficacy Prediction Model Based on Gastric Cancer Microenvironment Characteristics 2025.07.01 Progress in Clinical New Drugs and Translational Research on FGFR-Altered Gastric Cancer 2025.07.01 «previous next»
